New study tracks hidden risks of hepatitis b drugs in vulnerable patients
NCT ID NCT07529171
First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 2 times
Summary
This study follows 490 adults with a past hepatitis B infection who need immune-suppressing treatments. Researchers will monitor bone, kidney, and metabolic health over 4 years to understand the long-term side effects of antiviral drugs. The goal is to create better safety guidelines for these patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HBV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Akdeniz University, Faculty of Medicine, Department of Infectious Diseases and Clinical Mİcrobiology
RECRUITINGAntalya, Turkey (Türkiye)
-
Ankara Gazi University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology
RECRUITINGAnkara, Turkey (Türkiye)
-
Bilkent City Hospital Department of Infectious Diseases and Clinical Microbiology
RECRUITINGAnkara, Turkey (Türkiye)
-
Bolu Düzce University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology
RECRUITINGDüzce, Turkey (Türkiye)
-
Cukurova University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology
RECRUITINGAdana, Turkey (Türkiye)
-
Dicle University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology
RECRUITINGDiyarbakır, Turkey (Türkiye)
-
Diyarbakir, Memorial Hospital Department of Infectious Diseases and Clinical Microbiology
RECRUITINGDiyarbakır, Turkey (Türkiye)
-
Ege University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology
RECRUITINGIzmir, Turkey (Türkiye)
-
Gaziantep University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology
RECRUITINGGaziantep, Turkey (Türkiye)
-
Istanbul Haydarpaşa Numune Training and Research Hospital
RECRUITINGIstanbul, Turkey (Türkiye)
-
Istanbul Sancaktepe Martyr Prof. Dr. İlhan Varank Training and Research Hospital
RECRUITINGIstanbul, Turkey (Türkiye)
-
Kocaeli University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology
RECRUITINGKocaeli, Turkey (Türkiye)
-
Rize Recep Tayyip Erdogan University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology
RECRUITINGRize, Turkey (Türkiye)
-
Samsun Ondokuz Mayıs University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology
RECRUITINGSamsun, Turkey (Türkiye)
-
Sivas Cumhuriyet University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology
RECRUITINGSivas, Turkey (Türkiye)
-
Şanlıurfa Harran University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology
RECRUITINGSanliurfa, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A mobile app aims to turn health awareness into action — a trial puts it to the test
- Decade-Long study aims to unlock liver disease risks in HIV-Hepatitis b patients
- Austrian study seeks to eliminate hepatitis by linking patients to care
- Zambia study tracks hepatitis b outcomes in hundreds of patients
- New hepatitis b blood tests put to the test on 21,000 samples
- Gut check: new study probes how hepatitis drug changes your microbiome